The effect of treatment with pimobendan in dogs with preclinical mitral valve disease – a placebo-controlled double-blinded crossover study

The effect of treatment with pimobendan in dogs with preclinical mitral valve disease – a placebo-controlled double-blinded crossover study

Abstract Background Pimobendan is a widely used medication for the treatment of dogs with congestive heart failure (CHF) and preclinical degenerative mitral valve disease (DMVD) with cardiomegaly. The benefit of a treatment in dogs with preclinical DMVD but without cardiomegaly has not yet been eluc...

Full description

Bibliographic Details
Main Authors: Stephanie Klein, Ingo Nolte, Katja Rumstedt, Maximiliane Sehn, Jonathan Friedemann Raue, Franziska Weiner, Julia Sophie Treese, Martin Beyerbach, Jan-Peter Bach
Format: Article
Language:English
Published: BMC 2021-09-01
Series:BMC Veterinary Research
Subjects:
Dog
Pimobendan
Mitral valve disease
Crossover
Exercise test
Biomarker
Online Access:https://doi.org/10.1186/s12917-021-03014-5

Internet

https://doi.org/10.1186/s12917-021-03014-5

Similar Items